Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs
- PMID: 10958534
- DOI: 10.1136/vr.147.5.129
Use of the bisphosphonate drug alendronate for palliative management of osteosarcoma in two dogs
Abstract
The bisphosphonate drug alendronate was used to suppress bone remodelling and tumour osteolysis as a palliative treatment for two dogs with osteosarcoma, one of the tibia and one of the maxilla. A spiral fracture associated with the tibial tumour healed after it was stabilised with an external skeletal fixator. Both dogs remained comfortable and survived for 12 and 10 months respectively after diagnosis, despite the fact that neither primary tumour was resected.
Similar articles
-
The effect of the bisphosphonate alendronate on viability of canine osteosarcoma cells in vitro.In Vitro Cell Dev Biol Anim. 2004 Mar-Apr;40(3-4):113-7. doi: 10.1290/1543-706x(2004)040<0113:teotba>2.0.co;2. In Vitro Cell Dev Biol Anim. 2004. PMID: 15311969
-
Zoledronate-Associated Osteonecrosis of the Jaw in a Dog with Appendicular Osteosarcoma.J Vet Intern Med. 2016 Jul;30(4):1235-40. doi: 10.1111/jvim.13980. Epub 2016 Jun 14. J Vet Intern Med. 2016. PMID: 27296235 Free PMC article. No abstract available.
-
Single-agent pamidronate for palliative therapy of canine appendicular osteosarcoma bone pain.J Vet Intern Med. 2007 May-Jun;21(3):431-9. doi: 10.1892/0891-6640(2007)21[431:spfpto]2.0.co;2. J Vet Intern Med. 2007. PMID: 17552447
-
Palliative radiation therapy for canine osteosarcoma.Can Vet J. 2006 Jul;47(7):707-9. Can Vet J. 2006. PMID: 16898117 Free PMC article. Review. No abstract available.
-
Of dogs and men: comparative biology as a tool for the discovery of novel biomarkers and drug development targets in osteosarcoma.Pediatr Blood Cancer. 2012 Mar;58(3):327-33. doi: 10.1002/pbc.23341. Epub 2011 Oct 11. Pediatr Blood Cancer. 2012. PMID: 21990244 Review.
Cited by
-
Clodronate disodium does not produce measurable effects on bone metabolism in an exercising, juvenile, large animal model.PLoS One. 2024 Apr 16;19(4):e0300360. doi: 10.1371/journal.pone.0300360. eCollection 2024. PLoS One. 2024. PMID: 38626145 Free PMC article.
-
Retrospective assessment of tolerability and efficacy of zoledronate in the palliative treatment of cancer-bearing dogs.Aust Vet J. 2023 Jan;101(1-2):58-64. doi: 10.1111/avj.13218. Epub 2022 Nov 16. Aust Vet J. 2023. PMID: 36385598 Free PMC article.
-
Mitochondrial genome and functional defects in osteosarcoma are associated with their aggressive phenotype.PLoS One. 2018 Dec 21;13(12):e0209489. doi: 10.1371/journal.pone.0209489. eCollection 2018. PLoS One. 2018. PMID: 30576337 Free PMC article.
-
The effect of Zhangfei/CREBZF on cell growth, differentiation, apoptosis, migration, and the unfolded protein response in several canine osteosarcoma cell lines.BMC Vet Res. 2015 Feb 7;11:22. doi: 10.1186/s12917-015-0331-y. BMC Vet Res. 2015. PMID: 25890299 Free PMC article.
-
Prognostic factors in canine appendicular osteosarcoma - a meta-analysis.BMC Vet Res. 2012 May 15;8:56. doi: 10.1186/1746-6148-8-56. BMC Vet Res. 2012. PMID: 22587466 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical